Which medication would the nurse recognize as being in the drug class of choice for the treatment…

➤ Why might a clinician choose sacubitril/valsartan over an ACE inhibitor?
Sacubitril/valsartan (an ARNI) has shown greater reductions in mortality and heart failure hospitalizations than traditional ACE inhibitors for selected patients with HFrEF. Clinicians may switch when symptoms persist despite ACE inhibitor therapy. Stop ACE inhibitors at least 36 hours before starting an ARNI to lower the risk of angioedema.